Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

214 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
Iwamoto T, Okamoto H, Toyama Y, Momohara S. Iwamoto T, et al. Among authors: momohara s. FEBS J. 2008 Sep;275(18):4448-55. doi: 10.1111/j.1742-4658.2008.06580.x. Epub 2008 Jul 24. FEBS J. 2008. PMID: 18662305 Review.
Does Abatacept Increase Postoperative Adverse Events in Rheumatoid Arthritis Compared with Conventional Synthetic Disease-modifying Drugs?
Ito H, Tsuji S, Nakayama M, Mochida Y, Nishida K, Ishikawa H, Kojima T, Matsumoto T, Kubota A, Mochizuki T, Sakuraba K, Matsushita I, Nakajima A, Hara R, Haraguchi A, Matsubara T, Kanbe K, Nakagawa N, Hamaguchi M, Momohara S; JOSRA Consortium. Ito H, et al. Among authors: momohara s. J Rheumatol. 2020 Apr;47(4):502-509. doi: 10.3899/jrheum.181100. Epub 2019 Jun 15. J Rheumatol. 2020. PMID: 31203226
Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis.
Kanbori M, Suzuka H, Yajima T, Kishino E, Morishige R, Momohara S, Kawakami A, Ota M. Kanbori M, et al. Among authors: momohara s. Mod Rheumatol. 2018 Jan;28(1):66-75. doi: 10.1080/14397595.2017.1325058. Epub 2017 Jun 6. Mod Rheumatol. 2018. PMID: 28585869 Clinical Trial.
Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan.
Mimori T, Harigai M, Atsumi T, Fujii T, Kuwana M, Matsuno H, Momohara S, Takei S, Tamura N, Takasaki Y, Ikeuchi S, Kushimoto S, Koike T. Mimori T, et al. Among authors: momohara s. Mod Rheumatol. 2017 Sep;27(5):755-765. doi: 10.1080/14397595.2016.1265695. Epub 2016 Dec 21. Mod Rheumatol. 2017. PMID: 27919207
Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis.
Shidara K, Nakajima A, Inoue E, Hoshi D, Sugimoto N, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H. Shidara K, et al. Among authors: momohara s. J Rheumatol. 2017 Feb;44(2):147-153. doi: 10.3899/jrheum.160395. Epub 2016 Dec 1. J Rheumatol. 2017. PMID: 27909083
Evaluation of the efficacy and safety of etanercept 50 mg once weekly in Japanese patients with rheumatoid arthritis and comparison with 25 mg etanercept twice weekly.
Mochizuki T, Momohara S, Yano K, Shirahata T, Ikari K. Mochizuki T, et al. Among authors: momohara s. Mod Rheumatol. 2013 Sep;23(5):994-1000. doi: 10.1007/s10165-012-0790-y. Epub 2012 Nov 9. Mod Rheumatol. 2013. PMID: 23138447
Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products.
Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N. Okamoto H, et al. Among authors: momohara s. J Rheumatol. 2008 May;35(5):752-6. Epub 2008 Mar 1. J Rheumatol. 2008. PMID: 18322992
Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association.
Suzuki M, Nishida K, Soen S, Oda H, Inoue H, Kaneko A, Takagishi K, Tanaka T, Matsubara T, Mitsugi N, Mochida Y, Momohara S, Mori T, Suguro T. Suzuki M, et al. Among authors: momohara s. J Orthop Sci. 2011 Nov;16(6):778-84. doi: 10.1007/s00776-011-0142-3. Epub 2011 Aug 27. J Orthop Sci. 2011. PMID: 21874335
Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis.
Niki Y, Matsumoto H, Hakozaki A, Mochizuki T, Momohara S. Niki Y, et al. Among authors: momohara s. J Orthop Sci. 2010 Jan;15(1):57-63. doi: 10.1007/s00776-009-1410-3. Epub 2010 Feb 12. J Orthop Sci. 2010. PMID: 20151252
An association between amino acid position 74 of HLA-DRB1 and anti-citrullinated protein antibody levels in Japanese patients with anti-citrullinated protein antibody-positive rheumatoid arthritis.
Terao C, Suzuki A, Ikari K, Kochi Y, Ohmura K, Katayama M, Nakabo S, Yamamoto N, Suzuki T, Iwamoto T, Yurugi K, Miura Y, Maekawa T, Takasugi K, Kubo M, Saji H, Taniguchi A, Momohara S, Yamamoto K, Yamanaka H, Mimori T, Matsuda F. Terao C, et al. Among authors: momohara s. Arthritis Rheumatol. 2015 May;67(8):2038-45. doi: 10.1002/art.39133. Arthritis Rheumatol. 2015. PMID: 25832994
Combinations of the amino acid residues at position 74 and position 60 or 57 could induce improvement in Akaike's information criterion comparable to that induced by the 5 significant HLA-DRB1 alleles (HLA-DRB1*08:03, DRB1*09:01, DRB1*14:06, DRB1*15:01, and DRB1*15:02). .. …
Combinations of the amino acid residues at position 74 and position 60 or 57 could induce improvement in Akaike's information criteri …
214 results
Jump to page
Feedback